Navdeep Chandel 1 source tracked
Cell biologist and professor at Northwestern University studying mitochondrial metabolism and its role in cancer, aging, and disease.
About Navdeep Chandel →
Navdeep S. Chandel is the David W. Cugell Distinguished Professor of Medicine and of Biochemistry & Molecular Genetics at Northwestern University's Feinberg School of Medicine, where he leads a research lab within the Pulmonary and Critical Care Medicine Division. His work focuses on mitochondria as signaling organelles, showing that mitochondrial reactive oxygen species (ROS) and metabolites regulate physiology and disease beyond ATP production, with implications for cancer, immunology, aging, and neurodegeneration. He earned his B.A. in mathematics and Ph.D. in cell physiology from the University of Chicago and is the author of the textbook "Navigating Metabolism," published by Cold Spring Harbor Laboratory Press.
-
Organic (prompted) In a protocol
Chandel suggests citrulline supplementation for those on metformin, since metformin lowers blood citrulline, potentially impairing vasodilation and exercise response.
“if you're taking metformin, take citrulline
TP▶ 1:02:01CaveatsMechanism via NO/vasodilation is speculativeCertaintyhedgedrecommendation -
In a protocol
Chandel suggests using a CGM during a metformin trial to see if postprandial glucose spikes are being blunted.
“You have a glucose monitor or you do it for three months
TP▶ 1:05:20DosageUse for ~3 months to assess metformin's effect on glucose spikesCertaintyhedgedrecommendation -
Metformin may lower inflammation via complex I inhibition in alveolar macrophages, potentially reducing IL-6 from air pollution exposure.
“metformin... lowered the IL-6
TP▶ 2:01:00CaveatsHuman trials not yet done for pollution/inflammation endpointCertaintyspeculativerecommendation -
Organic (prompted) In a protocol
Chandel considers metformin before meals to blunt postprandial glucose spikes in pre-diabetic or insulin-resistant people; weak case for insulin-sensitive individuals.
“metformin abrogates that [glucose spike]... 30 minutes before a meal
TP▶ 1:46:17DosageTake ~30 minutes before mealsCaveatsCan cause B12 deficiency and lower citrulline; may blunt exercise-induced VO2max/hypertrophy gainsCertaintyhedgedrecommendation -
People in selenium-deficient regions (Northern New Zealand, Sweden, Finland) may benefit from supplementation to support GPX4 function against lipid peroxides.
“Some countries may have low selenium, so they may want to take selenium
TP▶ 16:40CaveatsUS diet is already high in seleniumCertaintyhedgedrecommendation -
Chandel mentions topical vitamin C supports skin collagen prolyl hydroxylases (alpha-KG dioxygenases) keeping skin healthy with age.
“the vitamin C that people like to put on their skin... collagen prolyl hydroxylases
TP▶ 22:40Certaintyhedgedoffhand mention -
In a protocol
Chandel recommends B12 supplementation for those on metformin because metformin reduces B12 absorption in the gut.
“B12 levels go down with metformin. So people should take B12
TP▶ 1:02:44Certaintyexplicitrecommendation -
Alternative
If considering berberine for glucose lowering, Chandel suggests just taking metformin instead—they appear to act via the same complex I mechanism, and metformin is cheaper and regulated.
“metformin is probably cheaper than berberine and is regulated. Use metformin
TP▶ 1:23:40Certaintyexplicitmild caution -
Organic (prompted)
CoQ10 may have a rationale in statin users with muscle symptoms but trials have been unimpressive; not recommended for general health in people with adequate CoQ10 levels.
“for normal health. No, you have enough coq
TP▶ 1:49:57CaveatsBioavailability problems; trials not very positiveCertaintyhedgedmild caution -
Organic (prompted)
Chandel warns against high-dose antioxidant supplementation: most people have sufficient capacity, and excessive intake may interfere with needed H2O2 signaling (e.g., impairing immune function, worsening some cancers).
“the antioxidant trials in those cases... made it worse
TP▶ 19:10CaveatsSelenium or vitamin C deficiency correction may still be warranted in deficient populationsCertaintyexplicitmild caution -
Organic (prompted)
Chandel strongly discourages hyperbaric oxygen therapy outside of wound healing; high oxygen causes senescence of lung epithelial cells.
“No, please don't. ... This one is for sure bad.
TP▶ 1:55:31CaveatsException: wound healing has valid indicationCertaintyexplicitstrong warning -
Organic (prompted)
Chandel doubts carnitine supplementation is useful since most people—including non-meat-eaters—get enough endogenously to run fatty acid oxidation.
“even people who don't eat meat... probably get sufficient amount
TP▶ 1:48:31Certaintyhedgedmild caution -
Organic (prompted)
Mechanism intriguing (shuttles electrons bypassing complex I/III) but therapeutic window is narrow due to monoamine oxidase inhibition risk; not endorsed for general use.
“the therapeutic window of that drug is pretty narrow
TP▶ 1:55:00CaveatsRisk of serotonin toxicity especially with SSRIs via MAO inhibitionCertaintyhedgedmild caution -
Organic (prompted)
Chandel does not recommend NAD precursors for general geroprotection; NAD levels don't appear rate-limiting in normal aging. Possibly useful for specific conditions like liver regeneration.
“not for geroprotective. I just don't see how
TP▶ 1:51:15CaveatsFailed in ITP mouse longevity trialsCertaintyexplicitmild caution -
Organic (prompted)
Chandel does not see justification for SS-31 as a general mitochondrial booster; cardiolipin is not rate-limiting in healthy people.
“for you and I, and for most people, I just don't see that
TP▶ 1:52:45CaveatsTarget/mechanism poorly definedCertaintyexplicitmild caution -
Organic (prompted)
Chandel is unconvinced by urolithin A for general use—mechanism (mitophagy) target is unclear and bioavailability is poor; possible niche use in anti-tumor immunity.
“I don't see any data... not enough to make me say let's use that
TP▶ 1:27:40CaveatsRapidly glucuronidated in liver; free urolithin barely detectable in plasmaCertaintyhedgedmild caution -
Organic (prompted)
Chandel sees mechanistic promise in alpha-ketoglutarate for maintaining DNA demethylase activity, but questions if endogenous levels are ever rate-limiting; potential niche uses like colitis or gut health.
“I like that one a lot and I study it myself
TP▶ 1:42:48CaveatsCells only need ~100 micromolar; unclear if supplementation raises levels where limitingCertaintyspeculativeoffhand mention